Phospho-CD22 (Y807) Antibody

What is CD22 and why is phosphorylation at Y807 significant?

CD22 (also known as Siglec-2 or BL-CAM) is a B cell-specific 130-140 kDa type 1 integral membrane glycoprotein that functions as an inhibitory co-receptor on B cells. Its cytoplasmic domain contains six tyrosine residues that can be phosphorylated, each with distinct functional roles :

• Y762, Y822, and Y842: Associated with immunoreceptor tyrosine-based inhibitory motifs (ITIMs)

• Y807: Part of the GRB2 binding region

• Y752 and Y796: Functions not well defined

Y807 phosphorylation is particularly significant because it creates a binding site for the SH2 domain of the adaptor protein GRB2. When phosphorylated, Y807 is part of the Y-E/Q-N-Φ motif (where Φ represents a hydrophobic amino acid) that facilitates this interaction . Unlike the inhibitory signaling through ITIMs, the pY807-GRB2 interaction forms a complex with SHIP and activates a MAP kinase pathway that can regulate cell survival and proliferation .

What experimental techniques induce CD22-Y807 phosphorylation?

Several approaches can be used to induce and study CD22-Y807 phosphorylation:

When monitoring phosphorylation, researchers typically normalize pY807 signals to total immunoprecipitated CD22 to account for expression level differences .

What antibody validation methods ensure specificity for phospho-Y807?

Rigorous validation of phospho-specific antibodies is critical for reliable results:

• Peptide Competition Assays: Phospho-CD22 (Y807) antibody binding should be blocked by the phosphorylated peptide but not by non-phosphorylated peptide, confirming phospho-specificity .

• Genetic Validation: Testing antibody reactivity in CD22-knockout cells provides a critical negative control .

• Mutant Analysis: CD22 Y807F mutants (where tyrosine is replaced with phenylalanine) should show negative or greatly reduced signal with phospho-Y807 antibodies .

• Induction Controls: Comparing phosphorylation signals between unstimulated and stimulated conditions (e.g., with pervanadate or anti-IgM) confirms the antibody detects stimulus-dependent phosphorylation .

• Cross-reactivity Testing: Antibodies should be tested against multiple phosphotyrosine motifs to ensure they don't recognize other phosphorylated residues within CD22 or other proteins .

How does PTP1B modulate CD22-pY807 and what are the implications for B cell function?

Protein Tyrosine Phosphatase 1B (PTP1B) has been identified as a significant regulator of CD22 phosphorylation, with a particular preference for the Y807 site. This relationship has been characterized through multiple experimental approaches:

• Peptide-based Phosphatase Assays: PTP1B can dephosphorylate multiple CD22 phosphotyrosine residues in vitro, including peptides containing pY762, pY796, pY807, and pY822 .

• Substrate Identification in Cells: Studies using PTP1B trapping mutants (FLAG-PTP1B-D181A-Y46F) revealed that CD22-Y807F mutation significantly impairs PTP1B binding compared to wild-type CD22 and other Y-to-F mutants, suggesting pY807 is a preferred cellular substrate .

• Cellular Phosphatase Assays: In Ramos B cells with inducible PTP1B expression, anti-λ BCR stimulation-induced phosphorylation of CD22 at Y807 is significantly reduced when PTP1B is expressed, with quantitative analysis showing clear reduction in pY807 signals when normalized to immunoprecipitated CD22 .

The functional implications of this regulation are significant for B cell biology:

• By dephosphorylating Y807, PTP1B can modulate GRB2 recruitment and subsequent signaling events, affecting B cell activation, proliferation, and survival pathways.

• This regulatory mechanism represents a novel point of control in B cell signaling that operates distinctly from the ITIM-SHP-1 inhibitory axis.

• The balance between kinase-mediated phosphorylation and PTP1B-mediated dephosphorylation of Y807 likely contributes to the fine-tuning of B cell responses to antigens.

What is the relationship between CD22 N-glycosylation and Y807 phosphorylation?

The relationship between CD22's extracellular N-glycosylation and intracellular Y807 phosphorylation reveals an unexpected connection between protein structure and signaling function:

Researchers discovered that mutation of N-glycan sites in CD22's extracellular domain (specifically in the 5Q-mutant where multiple N-glycan sites were altered) severely diminishes CD22 phosphorylation at Y807, Y822, and Y842 upon BCR stimulation . This effect is specific to BCR stimulation, as direct CD22 crosslinking with anti-CD22 antibodies still induces normal phosphorylation at Y822 in these N-glycan mutants .

The functional consequences are significant:

• Enhanced BCR Signaling: The reduced CD22 phosphorylation in N-glycan mutants leads to enhanced phosphorylation of downstream signaling molecules including PLCγ2, CD19, Akt, and ERK upon BCR stimulation .

• Altered Calcium Flux: Calcium flux induced by BCR stimulation is significantly increased in 5Q-mutant cells compared to WT CD22 cells, with a magnitude similar to CD22-knockout cells .

• Spatial Organization Effects: N-glycosylation affects CD22's organization in the cell membrane and its ability to form nanoclusters, which correlates with its ability to become phosphorylated upon BCR stimulation .

This relationship demonstrates how post-translational modifications in the extracellular domain can critically influence intracellular signaling functions, highlighting the integrated nature of receptor structure and function in immune regulation.

How does CD22-pY807 interact with GRB2 and what downstream signaling pathways are affected?

The interaction between phosphorylated CD22-Y807 and the adaptor protein GRB2 represents a crucial signaling node in B cell biology:

• Binding Mechanism: When phosphorylated, Y807 forms part of a Y-E/Q-N-Φ motif that serves as a specific binding site for the SH2 domain of GRB2 . This interaction is highly phosphorylation-dependent, as demonstrated by the significant reduction in GRB2 binding to CD22-Y807F mutants .

• Signaling Complex Formation: The pY807-GRB2 interaction facilitates the formation of a complex with other signaling molecules including SHIP (SH2-containing inositol phosphatase) and Shc, creating a signaling hub .

• Calcium Regulation: Research has shown that CD22 can associate with plasma membrane calcium ATPase (PMCA) to enhance calcium efflux after BCR ligation, and this association requires CD22 tyrosine phosphorylation . The Y807 site that associates with GRB2 must be phosphorylated for this interaction, and GRB2 is required for CD22's association with PMCA .

• Downstream Pathway Activation:

  • MAP kinase pathway activation, influencing B cell survival and proliferation

  • Regulation of calcium flux through PMCA association

  • Potential modulation of BCR-proximal signaling events

• Stimulus-Dependent Signaling: BCR ligation leads to rapid tyrosine phosphorylation of both the ITIMs and the GRB2 recruitment motif (Y807), while CD40 ligation primarily induces phosphorylation of the ITIM domains, suggesting context-dependent signaling outcomes .

This signaling axis represents a counterbalance to CD22's well-established inhibitory functions through ITIM motifs, highlighting the complex and multifaceted role of CD22 in regulating B cell responses.

How do different epitope-targeting strategies for CD22 affect receptor phosphorylation and function?

The specific epitope targeted on CD22 can significantly impact receptor function and downstream signaling events, with important implications for therapeutic approaches:

Recent research comparing different anti-CD22 antibodies and chimeric antigen receptors (CARs) has revealed that antibodies targeting different epitopes on CD22 demonstrate variable effects on receptor internalization, clustering, and signaling . The epitope position on CD22 relative to the cell membrane appears to influence therapeutic efficacy of CD22-targeted approaches .

Epitope Position Effects:

These findings highlight the importance of comprehensive epitope characterization when developing CD22-targeted therapeutics and suggest that targeting multiple distinct epitopes might provide advantages for preventing resistance in B-cell malignancies.

What are the critical controls for phospho-CD22 (Y807) antibody experiments?

For reliable interpretation of experiments using phospho-CD22 (Y807) antibodies, researchers should implement these essential controls:

Implementing these controls helps ensure that observed signals truly represent CD22 phosphorylation at Y807 rather than experimental artifacts or cross-reactivity with other phosphorylated epitopes.

How should researchers optimize protocols for detecting transient CD22-Y807 phosphorylation?

Due to the often transient and substoichiometric nature of tyrosine phosphorylation, detecting CD22-pY807 requires carefully optimized experimental protocols:

• Sample Preparation:

  • Add phosphatase inhibitors (sodium orthovanadate, NaF) to all buffers during cell lysis

  • Process samples rapidly at 4°C to prevent dephosphorylation

  • For Western blot applications, prepare lysates in buffer containing 1% Nonidet P-40, 150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 1 mM Na orthovanadate, 2 mM EDTA, 50 mM NaF and protease inhibitors

• Stimulation Optimization:

  • Determine the optimal anti-IgM F(ab')₂ concentration (typically 5-25 μg/ml) for your specific cell type

  • Perform detailed time-course experiments (0-30 minutes) to capture peak phosphorylation

  • Consider crosslinking efficiency in different buffers and temperatures

• Detection Methods:

  • Western blotting: Use recommended dilutions (1:500-1:2000) and optimize blocking conditions

  • Immunoprecipitation followed by Western blotting offers enhanced sensitivity for low abundance phosphorylation

  • Immunocytochemistry: Optimize fixation methods to preserve phospho-epitopes

• Signal Amplification:

  • Consider enhanced chemiluminescence substrates for Western blotting

  • Use tyrosine phosphatase inhibitors as positive controls to maximize signal

  • In flow cytometry applications, explore signal amplification strategies

• Quantification Approaches:

  • Always normalize phospho-signals to total CD22 levels

  • Include multiple technical and biological replicates

  • Use appropriate statistical methods for comparative analyses

These optimized protocols significantly increase the likelihood of detecting physiologically relevant changes in CD22-Y807 phosphorylation across experimental conditions.